Home » Topics » Regulatory » Patents

Patents
RSS

HMR describes new NCBE inhibitor series for cardiovascular disorders

April 29, 1999

Pyrazoles acting as modulators of cGMP production disclosed by Hoechst Marion Roussel

April 29, 1999

Triazine-based adenosine antagonists in development at Boehringer Ingelheim

April 29, 1999

New CRF antagonists described by DuPont for stress-related disorders

April 29, 1999

Potent, optically pure analogues of camptothecin designed at SCRAS

April 29, 1999

Continuing focus on PARP inhibitors at Guilford

April 29, 1999

Guilford's new PARP inhibitors potentially useful for wide variety of disorders

April 28, 1999

Tryptamine analogues as potent and selective human 5-HT2A antagonists

April 28, 1999

U.S. patent issued to NitroMed, providing protection for MED/FSAD treatment program

April 28, 1999

Inhibitors of NOS described by Pfizer

April 28, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Latus Bio series A financing supports early-stage programs
BioWorld Science
Latus Bio Inc. has closed a $97 million series A financing to support its broad therapeutics pipeline based on novel AAV capsid variants. Proceeds from the...